Role of intestinal flora in inflammatory bowel disease and probiotics place in their management;Role de la flore intestinale dans les maladies inflammatoires chroniques de l'intestin et place des probiotiques dans leur prise en charge

Tunisie Medicale

Volumn 83, Issue 3, 2005, Pages 132-136

  Belkahla, Néziha ^a   Maamouri, Nadia ^a   Ouerghi, Hajer ^a   Ammar, Ahmed Ben ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Crohn's disease; Intestinal flora; Pouchitis; Probiotics; Treatment; Ulcerative colitis

Indexed keywords

PROBIOTIC AGENT;

CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; HUMAN; ILEITIS; IMMUNE SYSTEM; INFLAMMATION; INGESTION; INTESTINE FLORA; NONHUMAN; REVIEW;

ANIMALS; COLITIS, ULCERATIVE; CONTROLLED CLINICAL TRIALS; CROHN DISEASE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; POUCHITIS; PROBIOTICS; RATS;

EID: 17844405573     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Desreumaux P, Colombel JF .Flore intestinale et maladies inflammatoires chroniques de l'intestin. Gastroentérol Clin Biol 2001 ; 25 : C89-93.
2. Sartor RB.Microbial agents in the pathogenesis différential diagnosis and complications of inflammatory bowel disease Infections of the gastro-intestinal tract. New-york: Raven Press 1995 : 435-58.
3. Cartun RW - Van Kruiningen HJ, Pedersen CA, Berman MM.An. Immunocytochemical search for infectious agents in Crohn's disease. Mod Pathol 1993; 6 ; 212-9.
4. Tabaqchali S, O'Donoghue DP, Bettelheim KA .Escherichia coli antibodies in patients with inflammatory bowel disease ; Gut 1978 : 19: 108-13.
5. Rutgeerts P, Geboes K, Peeters M, Hiele M, Penninckx F. Aerts R et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991 : 338 : 771-4.
6. Lederman E, Neut C, Desreumaux P, Klein O, Gambiez L, Cortot A et al. Bacterial overgrowth in the neoterminal ileum after ileo-colonic resection for Crohn's disease (abstract) .Gastroenterology 1997 ; 112 : 1023.
7. Harper PH, Lee EC, Kettlewell MGW, Bennett MK, Jewell DP.Role of the feacal stream in the maintenance of Crohn's colitis. Gut 1985 : 26: 279-84.
8. Ruseler-Van Embden JG, Both-Patoir HC Anaerobic gram-negative faecal flora in patients with crohn's disease and health subjects. Antonie Van Leeuwenhoek 1983: 49 : 125-32.
9. Keighley MRB, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander W J. Influence of inflammatory bowel disease on intestinal microflora .Gut 1978: 19: 1099-104.
10. Peach S, Lock MR., Katz D, Todd IP, Tabacqchali S. Mucosoal-associated bacterial flora on the intestine in patients with crohn's disease and in a control group.Gut 1978 ; 19 : 1034-42.
11. Favier C, Neut C, Mizon C, Cortot A, Colombel JF,Mizon J. D-Galactosidase production and bifidobacteria are decreased in crohn's disease .Dig Dis Sci 1997 ; 42 : 817-22.
12. Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980 ; 21: 793-8.
13. Grimm MC, Pavli P, Van de Pol E, Doe WF. Evidence for a CD14 + population of monocytes in inflammatory bowel disease mucosa: implication for pathogenesis. Clin. Exp. Immunol 1995 ; 100 : 291-7.
14. Garcia-Lafuente A, Antolin M, Crespo E. Intestinal permeability is modulated by the composition of the commensal flora (abstract).Gastroenterology 1997 ; 112 : 979.
15. Komatsu S, Panes J, Mori N, Grisham MB, Granger DN .Effects of intestinal stasis on ICAM-1 expression: role of enteric bacteria (abstract). Gastrenterology 1997 ; 112 : 1018.
16. Duchmann R ,. Kaiser I, Hermann E, MayeT W, Ewe K, Meyer zum, Buschenfelde KH .Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease.Clin Exp Immunol 1995 ; 102 : 448-55.
17. Marteau F, Jian R. Nutrition et maladies inflammatoires cryptogénétiques de l'intestin : quoi de neuf ? Post'U - FMC - HGE - Lettre no 22. Paris, 29-30 Mars 2003 ; 70-4.
18. Marteau P, Seksik P .Place des prébiotiques et probiotiques dans la prise en charge thérapeutique des maladies inflammatoires cryptogénétiques de l'intestin. Gastroentérol Clin Biol 2001; 25 : C94-C97.
19. Malshow HA. Crohn's disease and Escherchia Coli. A new approach in therapy to maintain remission of colonic crohn's disease ? S. Clin. Gastroenterol 1997 ; 25 : 653-8.
20. Kruis W, Schrütz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherchia Coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997 ; 11 : 853-8.
21. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherchia Coli versus mesalazine for the treatment of ulcerative colitis : a randomized trial. Lancet 1999 ; 354 : 635-9.
22. Kruis W, Fric P, Stolte M. Maintenance of remission in ulcerative colitis is equally effective with Escherchia Coli. Nissle 1997 and with standard mesalamine. Gastroenterology 2001 ; 120 : A 139.
23. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9.
24. Mimura T, Rizello F, Schreiber S, Talbot IC, Nicholls R, Gionchetti P,Campieri M, Kamm M .Once daily high dose probiotic therapy maintains remission and improved quality of life in patients with recurrent or refactory pouchitis ; a randomized, placebo-controlled double-blind trial.Gastroenterology 2002 ; 122 : A81.
25. Gionchetti, Rizello F, Venturi A ,Helwig U, Amadini C, Lammers KM, et al .Prophylaxis of pouchitis onset with probiotic therapy ; a double blind, placebo-controlled trial.Gastroenterology 2000 ; 118 : G1214.
26. Gampieri M., Rizello F., Venturi A, Poggioli G, Ugolini F, Helwig U, et al.Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of crohn's disease : a randomized controlled study vs mesalamine .Gastroenterology 2000 ; 118: G 4179.
27. Guslandi M, Mezzi G, Sorghi M, Testoni PA .Saccharyomices boulardii in maintenance treatment of crohn's disease. Dig Dis Sci 2000 ; 45 : 1462-4.
28. Gruslandi M. Probiotics for chronic intestinal disorders. AJG 2003; 98; 3: 520-21.
29. Prantera C, Scribano ML, FA-Lasco G, Andreoli A, Luzi C. Ineffectiveness of probiotic in preventing recurrence after curative resection for crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut 2002 ; 51 : 405-9.
30. Kuisma J, Mentula S, Jarvinen H, Kahris A, Saxelin M, Farkkila M. Effet of lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol ther 2003 ; 17 : 509-15.